title: Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man.
abstract: Splanchnic exchange of glucose, 20 individual amino acids, lactate, and pyruvate was studied in normal subjects in the postabsorptive state and after stimulation of endogenous insulin secretion by infusion of glucose at two dose levels. In the basal state, mean splanchnic glucose production was 3.4 mg/kg per min. A net uptake of lactate, pyruvate, and nine amino acids was observed, with alanine accounting for half of the total splanchnic-amino acid extraction. Infusion of glucose at 25 mg/kg per min for 20 min resulted in a fivefold increase in arterial insulin levels and in reversal of splanchnic glucose balance to a net uptake. Splanchnic uptake of alanine, glycine, phenylalanine, lactate, and pyruvate fell by 30-60% due to a reduction in fractional extraction of these substrates, inasmuch as their arterial concentrations did not decline.Administration of glucose at 2 mg/kg per min for 45 min resulted in a 19 mg/100 ml increase in arterial glucose concentration and a doubling of arterial insulin levels. Despite the small increment in insulin, hepatic glucose production fell by 85%. Splanchnic exchange of amino acids, lactate, and pyruvate was unaltered. Estimated total glucose utilization during the infusion was no greater than in the basal state, indicating lack of stimulation of peripheral glucose uptake. IT IS CONCLUDED THAT: (a) inhibition of hepatic glucose production associated with glucose infusion and large increments in insulin levels occurs in the absence of a decrease in the concentration of circulating gluconeogenic substrate, suggesting an hepatic rather than peripheral effect; (b) the liver is the primary target organ whereby glucose homeostasis is achieved with small increments in insulin; (c) the relatively greater sensitivity of the liver's response to insulin as compared with an effect of insulin on the peripheral tissues, may be a consequence of the higher levels of endogenous insulin in portal as compared with peripheral blood.
mesh_terms: D000328:Adult; D000409:Alanine / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism*; D002404:Catheterization; D003864:Depression, Chemical; D005215:Fasting; D005260:Female; D005943:Gluconeogenesis; D005947:Glucose / Q000494:pharmacology; D005998:Glycine / Q000378:metabolism; D006503:Hepatic Veins; D006706:Homeostasis; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007773:Lactates / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010649:Phenylalanine / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D011773:Pyruvates; D010649:Phenylalanine; D005947:Glucose; D000409:Alanine; D005998:Glycine